174 related articles for article (PubMed ID: 36727595)
1. Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model.
Christensen KD; McMahon PM; Galbraith LN; Yeh JM; Stout NK; Lu CY; Stein S; Zhao M; Hylind RJ; Wu AC
Genet Med; 2023 Apr; 25(4):100797. PubMed ID: 36727595
[TBL] [Abstract][Full Text] [Related]
2. Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts.
Brough J; Jain M; Jerves T; Kruszka P; McGuffey E
Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):124-128. PubMed ID: 32030882
[TBL] [Abstract][Full Text] [Related]
3. Population-Based Newborn Screening for Germline TP53 Variants: Clinical Benefits, Cost-Effectiveness, and Value of Further Research.
Kunst N; Stout NK; O'Brien G; Christensen KD; McMahon PM; Wu AC; Diller LR; Yeh JM
J Natl Cancer Inst; 2022 May; 114(5):722-731. PubMed ID: 35043946
[TBL] [Abstract][Full Text] [Related]
4. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives.
Norrish G; Jager J; Field E; Quinn E; Fell H; Lord E; Cicerchia MN; Ochoa JP; Cervi E; Elliott PM; Kaski JP
Circulation; 2019 Jul; 140(3):184-192. PubMed ID: 31006259
[TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death.
Anderson BR; McElligott S; Polsky D; Vetter VL
Pediatr Cardiol; 2014 Feb; 35(2):323-31. PubMed ID: 24005901
[TBL] [Abstract][Full Text] [Related]
6. Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity.
Alfares AA; Kelly MA; McDermott G; Funke BH; Lebo MS; Baxter SB; Shen J; McLaughlin HM; Clark EH; Babb LJ; Cox SW; DePalma SR; Ho CY; Seidman JG; Seidman CE; Rehm HL
Genet Med; 2015 Nov; 17(11):880-8. PubMed ID: 25611685
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
[TBL] [Abstract][Full Text] [Related]
8. Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights.
Yeh JM; Stout NK; Chaudhry A; Christensen KD; Gooch M; McMahon PM; O'Brien G; Rehman N; Blout Zawatsky CL; Green RC; Lu CY; Rehm HL; Williams MS; Diller L; Wu AC
Genet Med; 2021 Jul; 23(7):1366-1371. PubMed ID: 33767345
[TBL] [Abstract][Full Text] [Related]
9. Family screening for hypertrophic cardiomyopathy: Is it time to change practice guidelines?
Lafreniere-Roula M; Bolkier Y; Zahavich L; Mathew J; George K; Wilson J; Stephenson EA; Benson LN; Manlhiot C; Mital S
Eur Heart J; 2019 Dec; 40(45):3672-3681. PubMed ID: 31170284
[TBL] [Abstract][Full Text] [Related]
10. Patients With Hypertrophic Cardiomyopathy and Normal Genetic Investigations Have Few Affected Relatives.
Nielsen SK; Hansen FG; Rasmussen TB; Fischer T; Lassen JF; Madsen T; Møller DS; Klausen IC; Brodersen JB; Jensen MSK; Mogensen J
J Am Coll Cardiol; 2023 Oct; 82(18):1751-1761. PubMed ID: 37879779
[TBL] [Abstract][Full Text] [Related]
11. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
[TBL] [Abstract][Full Text] [Related]
12. Genetic Testing in Patients with Hypertrophic Cardiomyopathy.
Bonaventura J; Polakova E; Vejtasova V; Veselka J
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638741
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients.
Hathaway J; Heliö K; Saarinen I; Tallila J; Seppälä EH; Tuupanen S; Turpeinen H; Kangas-Kontio T; Schleit J; Tommiska J; Kytölä V; Valori M; Muona M; Sistonen J; Gentile M; Salmenperä P; Myllykangas S; Paananen J; Alastalo TP; Heliö T; Koskenvuo J
BMC Cardiovasc Disord; 2021 Mar; 21(1):126. PubMed ID: 33673806
[TBL] [Abstract][Full Text] [Related]
15. Genetic testing in patients with hypertrophic cardiomyopathy.
Bonaventura J; Veselka J
Vnitr Lek; 2019; 65(10):652-658. PubMed ID: 31906687
[TBL] [Abstract][Full Text] [Related]
16. Hypertrophic Cardiomyopathy-Related Sudden Cardiac Death in Young People in Ontario.
Weissler-Snir A; Allan K; Cunningham K; Connelly KA; Lee DS; Spears DA; Rakowski H; Dorian P
Circulation; 2019 Nov; 140(21):1706-1716. PubMed ID: 31630535
[TBL] [Abstract][Full Text] [Related]
17. Genetic diagnosis of hypertrophic cardiomyopathy using mass spectrometry DNA arrays and high resolution melting.
Santos S; Lança V; Oliveira H; Branco P; Silveira L; Marques V; Brito D; Madeira H; Bicho M; Fernandes AR
Rev Port Cardiol; 2011 Jan; 30(1):7-18. PubMed ID: 21425739
[TBL] [Abstract][Full Text] [Related]
18. Molecular autopsy and family screening in a young case of sudden cardiac death reveals an unusually severe case of FHL1 related hypertrophic cardiomyopathy.
Gaertner-Rommel A; Tiesmeier J; Jakob T; Strickmann B; Veit G; Bachmann-Mennenga B; Paluszkiewicz L; Klingel K; Schulz U; Laser KT; Karger B; Pfeiffer H; Milting H
Mol Genet Genomic Med; 2019 Aug; 7(8):e841. PubMed ID: 31293105
[TBL] [Abstract][Full Text] [Related]
19. Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center.
Mazzarotto F; Girolami F; Boschi B; Barlocco F; Tomberli A; Baldini K; Coppini R; Tanini I; Bardi S; Contini E; Cecchi F; Pelo E; Cook SA; Cerbai E; Poggesi C; Torricelli F; Walsh R; Olivotto I
Genet Med; 2019 Feb; 21(2):284-292. PubMed ID: 29875424
[TBL] [Abstract][Full Text] [Related]
20. Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.
Jääskeläinen P; Vangipurapu J; Raivo J; Kuulasmaa T; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Vanninen S; Hämäläinen L; Melin J; Kokkonen J; Nieminen MS; ; Laakso M; Kuusisto J
ESC Heart Fail; 2019 Apr; 6(2):436-445. PubMed ID: 30775854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
